Research

Paige Vega, a Ph.D. student in the Department of Cell and Developmental Biology, has been selected as the 2021 Vanderbilt Prize Student Scholar. Read More

Professor and entrepreneur finds startup success with Vanderbilt’s spirit of collaboration and innovation. Read More

Vanderbilt Blair creates Curso Virtual de Dirección de Banda, a remote learning program for music directors in Latin America that covers instrument pedagogy, conducting techniques and other topics in band direction. Read More

Thomas Talbot, professor of medicine and chief hospital epidemiologist at Vanderbilt University Medical Center, shares the latest available information on when COVID-19 vaccines will be approved for children under 12. Read More

Vanderbilt neurologists found altered excitability in deep brain structures that they note may drive respiratory dysfunction and sudden death in a rare form of epilepsy. Read More

The Vanderbilt Project on Unity and American Democracy and Vanderbilt University Medical Center will host “Vaccine Hesitancy: The Politics of Public Health in Tennessee,” a virtual event, on Wednesday, Aug. 18, at noon CT. Read More

Rejecting conventional wisdom, a team of researchers found that store loyalty, purchase intentions and spending behavior are negatively affected when consumers encounter a salesperson who is standing close by. Read More

Vanderbilt University joined Nashville community leaders to pay tribute to the life and Nashville legacy of U.S. Rep. John Lewis with the formal dedication of Rep. John Lewis Way and a public celebration at Ryman Auditorium. Read More

Helicobacter pylori, a stomach-dwelling bacterium, is a strong risk factor for gastric cancer, peptic ulcers and other debilitating gastrointestinal disorders. Read More

Thomas Talbot, professor of medicine and chief hospital epidemiologist at Vanderbilt University Medical Center, shares what we know about when COVID-19 vaccines will be fully approved. Read More

Chemoresistant SW480 colon cancer cells stained for lipid rafts (green), death receptor 4 (red) and cell nuclei (blue). Image taken by Joshua Greenlee using a Zeiss LSM 880 from the Vanderbilt Cell Imaging Shared Resource Center. By Marissa Shapiro THE IDEA Vanderbilt faculty and researchers are looking for the “Achilles’ heel” of the cancer cells... Read More

Chemoresistant SW480 colon cancer cells stained for lipid rafts (green), death receptor 4 (red) and cell nuclei (blue). Image taken by Joshua Greenlee using a Zeiss LSM 880 from the Vanderbilt Cell Imaging Shared Resource Center. By Marissa Shapiro THE IDEA Vanderbilt faculty and researchers are looking for the “Achilles’ heel” of the cancer cells... Read More

Vanderbilt researchers discover that protein-coated nanoparticles kill more than half of cancer cells in the blood of patients with advanced chemo-resistant colon cancer. Est. reading time: 2.5 mins. Read More

Join the School of Medicine Basic Sciences’ monthly Lab-to-Table series for a conversation with former Tour de France and Olympic athletes about science and cycling. The discussion will touch on the athletes’ personal experiences with training, coaching and medicine in cycling and how biomedical science has shaped their efforts. The virtual event will be Tuesday, Aug. 17, at 11 a.m. CT. Read More

Two faculty from Peabody College of education and human development have been awarded grants totaling $4.5 million from the National Center for Special Education Research. Read More

Intelligent Systems, an indoor air quality monitoring startup founded by Tim Darrah, a Ph.D. student in computer science, has won a stage 2 grant from VentureWell, which funds and trains faculty and student innovators to create successful, socially beneficial businesses. Darrah grew Intelligent Systems through the Wond’ry, Vanderbilt’s Innovation Center. Read More

Thomas Talbot, professor of medicine and chief hospital epidemiologist at Vanderbilt University Medical Center, discusses what we know about the delta variant of COVID-19.  Read More

Vanderbilt University engineering and education faculty are part of a new $20 million research institute funded by the National Science Foundation that aims to create artificial intelligence tools to advance human learning and education. Read More

Following decades of worldwide research standstills on cancer drug improvement, Steven Townsend and his team of researchers synthesize cancer therapeutics that bypass toxicity aimed at heart health. Est. reading time: 2.5 minutes. Read More

Lisa Monteggia leads discovery of the gene responsible for ketamine’s long-term effects with implications for antidepressant therapeutics. Est. reading time: 2.5 mins. Read More